PRO68 Patient-Reported Outcomes in Patients with Pemphigus Vulgaris Treated with Rituximab in the Phase 3 PEMPHIX Study
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1053
https://www.valueinhealthjournal.com/article/S1098-3015(21)01270-5/fulltext
Title :
PRO68 Patient-Reported Outcomes in Patients with Pemphigus Vulgaris Treated with Rituximab in the Phase 3 PEMPHIX Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01270-5&doi=10.1016/j.jval.2021.04.1053
First page :
Section Title :
Open access? :
No
Section Order :
10549